Cryo Cell International Inc. Files Q1 2025 10-Q
Ticker: CCEL · Form: 10-Q · Filed: Apr 14, 2025 · CIK: 862692
| Field | Detail |
|---|---|
| Company | Cryo Cell International Inc (CCEL) |
| Form Type | 10-Q |
| Filed Date | Apr 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
CRYO CELL INT'L FILES Q1 10-Q: FINANCIALS & OPS UPDATE
AI Summary
Cryo Cell International Inc. filed its 10-Q for the period ending February 28, 2025. The filing details financial information and business operations for the first quarter of fiscal year 2025. Key financial data and operational segments, such as public cord blood banking and prepacitecb, are presented for the reporting period.
Why It Matters
This filing provides investors and stakeholders with an update on Cryo Cell International's financial performance and operational status for the first quarter of fiscal year 2025.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the nature of the biotech/health services industry can carry inherent risks.
Key Players & Entities
- CRYO CELL INTERNATIONAL INC (company) — Filer
- 20250228 (date) — Period of Report
- 20250414 (date) — Filed as of Date
- 813-749-2104 (phone_number) — Business Phone
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250228, indicating the period ending February 28, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on 1130.
What is the company's primary business address?
The business address is 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR, FL 34677.
What are some of the operating segments mentioned in the filing?
The filing mentions 'ccel:PrepacytecbMember' and 'ccel:PublicCordBloodBankingMember' as operating segments.
When was the company incorporated?
The State of Incorporation is DE (Delaware).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 14, 2025 regarding CRYO CELL INTERNATIONAL INC (CCEL).